Impact of atrial fibrillation and the clinical outcomes in patients with acute myocardial infarction from the K-ACTIVE registry

Schmitt, 2009, Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications, Eur Heart J, 30, 1038, 10.1093/eurheartj/ehn579

Kinjo, 2003, Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention, Am J Cardiol, 92, 1150, 10.1016/j.amjcard.2003.07.021

Miyasaka, 2006, Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence, Circulation, 114, 119, 10.1161/CIRCULATIONAHA.105.595140

Pedersen, 1999, The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction, Eur Heart J, 20, 748, 10.1053/euhj.1998.1352

Pizzetti, 2001, Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data, Heart, 86, 527, 10.1136/heart.86.5.527

Lopes, 2008, Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation, Heart, 94, 867, 10.1136/hrt.2007.134486

Berton, 2009, Atrial fibrillation during acute myocardial infarction: association with all-cause mortality and sudden death after 7-year of follow-up, Int J Clin Pract, 63, 712, 10.1111/j.1742-1241.2009.02023.x

Roy, 1983, Atrial tachycardia facilitating initiation of ventricular tachycardia, Pacing Clin Electrophysiol, 6, 47, 10.1111/j.1540-8159.1983.tb06581.x

Grönefeld, 2000, Association between atrial fibrillation and appropriate implantable cardioverter defibrillator therapy: results from a prospective study, J Cardiovasc Electrophysiol, 11, 1208, 10.1046/j.1540-8167.2000.01208.x

Valgimigli, 2018, 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS, Eur Heart J, 39, 213, 10.1093/eurheartj/ehx419

Levine, 2016, 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, J Am Coll Cardiol, 68, 1082, 10.1016/j.jacc.2016.03.513

Capodanno, 2018, ACC/AHA versus ESC guidelines on dual antiplatelet therapy: JACC guideline comparison, J Am Coll Cardiol, 72, 2915, 10.1016/j.jacc.2018.09.057

Nakamura, 2020, JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease, Circ J, 84, 831, 10.1253/circj.CJ-19-1109

Mehta, 2003, Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation, Am J Cardiol, 92, 1031, 10.1016/j.amjcard.2003.06.001

Thygesen, 2012, Third universal definition of myocardial infarction, Eur Heart J, 33, 2551, 10.1093/eurheartj/ehs184

Mehran, 2011, Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium, Circulation, 123, 2736, 10.1161/CIRCULATIONAHA.110.009449

Kato, 2015, Cardioembolic stroke is the most serious problem in the aging society: Japan standard stroke registry study, J Stroke Cerebrovasc Dis, 24, 811, 10.1016/j.jstrokecerebrovasdis.2014.11.019

González-Pacheco, 2015, Clinical features and in-hospital mortality associated with different types of atrial fibrillation in patients with acute coronary syndrome with and without ST elevation, J Cardiol, 66, 148, 10.1016/j.jjcc.2014.11.001

Obayashi, 2021, Newly diagnosed atrial fibrillation in acute myocardial infarction, J Am Heart Assoc, 10, 10.1161/JAHA.121.021417

Inoue, 2020, Extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest in adult patients, J Am Heart Assoc, 9, 10.1161/JAHA.119.015291

Natsuaki, 2018, Prediction of thrombotic and bleeding events after percutaneous coronary intervention: CREDO-Kyoto thrombotic and bleeding risk scores, J Am Heart Assoc, 7, 10.1161/JAHA.118.008708

Cannon, 2017, Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation, New Engl J Med, 377, 1513, 10.1056/NEJMoa1708454

Gibson, 2016, Prevention of bleeding in patients with atrial fibrillation undergoing PCI, New Engl J Med, 375, 2423, 10.1056/NEJMoa1611594

Lopes, 2019, Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation, New Engl J Med, 380, 1509, 10.1056/NEJMoa1817083

Vranckx, 2019, Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial, Lancet, 394, 1335, 10.1016/S0140-6736(19)31872-0

Capodanno, 2018, ACC/AHA versus ESC guidelines on dual antiplatelet therapy, J Am Coll Cardiol, 72, 2915, 10.1016/j.jacc.2018.09.057

Urban, 2019, Defining high bleeding risk in patients undergoing percutaneous coronary intervention, Circulation, 140, 240, 10.1161/CIRCULATIONAHA.119.040167

Watanabe, 2019, Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial, JAMA, 321, 2414, 10.1001/jama.2019.8145

Yasuda, 2019, Antithrombotic therapy for atrial fibrillation with stable coronary disease, New Engl J Med, 381, 1103, 10.1056/NEJMoa1904143